Over four years ago, the International Society of Glomerular Disease (ISGD) began as a shared idea and vision: to create a global home for clinicians and researchers focused on glomerular disease, and to accelerate progress through ...

Today marks a turning point for people living with focal segmental glomerulosclerosis (FSGS). More than a hundred years after the disease was first defined, the U.S. Food and Drug Administration (FDA) has granted its first ever approval of ...